U.S. Professional Services Stock News

Ironwood Pharmaceuticals (IRWD) opened 2026 with Q1 revenue of US$106.5 million and basic EPS of US$0.25, alongside net income of US$40.8 million, putting fresh quarterly figures in front of a market that has been closely watching its profitability profile. Over the past year, the company has seen trailing twelve month revenue move between US$296.2 million and US$361.5 million while trailing EPS shifted from US$0.15 to US$0.63, giving investors a fuller picture of how earnings power has...

Haemonetics (HAE) has just wrapped up FY 2026 with fourth quarter revenue of US$346.4 million and a basic EPS loss of US$0.44, alongside trailing twelve month revenue of about US$1.33 billion and EPS of US$2.06. Over the last two reported years, quarterly revenue has moved within a tight band from US$321.4 million to US$348.5 million while basic EPS has ranged from US$0.71 to US$1.18 in profitable quarters, before the recent loss. With a trailing net profit margin of 7.3% affected by a one...

Delcath Systems (DCTH) opened 2026 with Q1 revenue of about US$25.0 million and a basic EPS loss of roughly US$0.03, while trailing twelve month revenue stood at US$90.4 million and basic EPS was US$0.02. Over the past reported periods, quarterly revenue ranged from US$15.1 million in Q4 2024 to US$24.2 million in Q2 2025, with basic EPS moving between a loss of US$0.11 in Q4 2024 and a profit of US$0.08 in Q2 2025. This gives investors a clear view of how top line scale and profitability...

Houlihan Lokey (HLI) has just wrapped up FY 2026 with fourth quarter revenue of US$635.6 million and basic EPS of US$1.50. Trailing 12 month revenue came in at about US$2.6 billion and EPS at US$6.40. Over recent periods, revenue has moved between US$605.3 million and US$717.1 million per quarter, with quarterly EPS ranging from US$1.47 to US$1.84. Trailing 12 month EPS has stepped up from US$5.49 to US$6.40, giving investors a view of how the earnings base has evolved. With a trailing net...

Icahn Enterprises (IEP) opened Q1 2026 with revenue of US$2,206 million and a basic EPS loss of US$0.71, while trailing 12 month figures show revenue of US$9.7 billion and a basic EPS loss of US$0.56. Over recent quarters the company has seen quarterly revenue move from US$1,868 million in Q1 2025 to US$2,206 million in Q1 2026, with basic EPS shifting from a loss of US$0.79 to a loss of US$0.71 as investors assess how margins may stabilize from these loss-making levels. See our full analysis...

American Homes 4 Rent (AMH) just posted Q1 2026 results with revenue of US$472.0 million and basic EPS of US$0.35, setting the tone for how investors read the latest move in profitability. Over recent quarters, revenue has moved from US$436.6 million in Q4 2024 to US$459.3 million in Q1 2025 and US$454.9 million in Q4 2025, while trailing 12 month EPS has shifted from US$1.08 in Q4 2024 to US$1.23 in Q1 2026. This provides a clear earnings backdrop as you weigh how sustainable the current...

Snap (SNAP) Q1 2026 earnings snapshot Snap (SNAP) kicked off 2026 with Q1 revenue of US$1.5 billion and a basic EPS loss of US$0.05 as the company continued to trade around US$5.98 a share. Over recent quarters, revenue has moved from US$1.36 billion in Q1 2025 to US$1.53 billion in Q1 2026, while basic EPS has moved between a loss of US$0.08 in Q1 2025, a small profit of US$0.03 in Q4 2025, and back to a modest loss this quarter. This has left investors focused on how quickly margins can...

MarketAxess Holdings (MKTX) opened 2026 with Q1 revenue of US$233.4 million and basic EPS of US$2.21, while trailing twelve month revenue stood at US$871.1 million and basic EPS at US$8.47. This gives investors a clear snapshot of current scale and earnings power. The company has seen quarterly revenue move from US$208.6 million in Q1 2025 to US$233.4 million in Q1 2026, with basic EPS shifting from US$0.40 to US$2.21 over the same period. This sits against a trailing net margin of 35.5%,...

Riley Exploration Permian (REPX) opened 2026 with Q1 revenue of US$113.9 million and a basic EPS loss of US$3.38, compared with Q1 2025 revenue of US$102.5 million and basic EPS of US$1.36, while trailing 12 month EPS sits at US$2.93 on revenue of US$403.4 million. Over recent quarters, the company has seen revenue move from US$85.4 million in Q2 2025 to US$97.3 million in Q4 2025 and then to US$113.9 million in Q1 2026. Basic EPS shifted from US$1.44 to US$4.04 before the latest quarterly...

ImmunityBio (IBRX) opened Q1 2026 with revenue of US$44.2 million and a basic EPS loss of US$0.62, alongside a net income loss of US$632.8 million, putting a sharp spotlight on how much cash the business is burning to drive its pipeline. The company has seen quarterly revenue move from US$7.6 million in Q4 2024 to US$16.5 million in Q1 2025, US$38.3 million in Q4 2025 and now US$44.2 million in Q1 2026, while quarterly basic EPS has stayed in loss territory over the same stretch. The key...

Tapestry (TPR) has just posted its Q3 2026 numbers, with revenue at US$1,920.6 million and basic EPS of US$1.70. Trailing twelve month revenue sits at US$7.9 billion and EPS at US$3.22 as investors weigh these figures against the prior year’s large one off loss that pulled net profit margin down to 8.4% from 12.5%. With earnings forecast to grow 18.4% a year on revenue growth of 4.6%, and the latest quarter slotting into that backdrop, the key question is how much of this earnings power can...

Array Technologies (ARRY) opened Q1 2026 with revenue of US$223.4 million and a basic EPS loss of US$0.09, alongside a net income loss of US$13.5 million. These results put fresh numbers around a business that is still working through negative margins. The company’s quarterly revenue has moved from US$302.4 million and EPS of US$0.02 in Q1 2025 to US$223.4 million and an EPS loss of US$0.09 in the latest quarter. This frames a story where top-line scale is in place but profitability remains...

Magnera (MAGN) opened Q2 2026 with total revenue of US$796 million and a basic EPS loss of US$0.50, setting the stage for another quarter where investors are watching how fast the income statement can move toward break even. Over the past six reported quarters, revenue has ranged between US$702 million and US$839 million while quarterly basic EPS has moved from a loss of US$1.69 to a loss of US$0.50. This gives investors a clear view of a business that is still loss making but with margins...

Ingles Markets (IMKT.A) has put up a steady Q2 2026 print, with revenue at about US$1.3 billion and basic EPS of US$1.28, backed by trailing 12 month EPS of US$5.49 and net income of US$104.29 million. Over recent quarters the company has seen revenue move from roughly US$1.33 billion and EPS of US$0.80 in Q2 2025 to around US$1.31 billion and EPS of US$1.28 in the latest quarter. Over the same period, trailing net margin has lifted from 1.1% to 1.9%, giving you a set of results that point to...

Wondering whether Canadian Solar's share price still reflects its true worth, or if the market has moved ahead of the fundamentals? This article focuses squarely on what the current valuation might be telling you. After a period of sharp moves, with a 15.6% return over 7 days, 46.0% over 30 days, a 92.0% return over 1 year, and a year-to-date return of negative 30.4%, the stock has caught the eye of investors rethinking its risk and reward profile. These swings sit alongside a longer...

Fresh off its Q1 2026 report, Macerich (MAC) posted total revenue of US$231.7 million, a basic EPS loss of US$0.14, and funds from operations of US$92.4 million, keeping the focus firmly on cash generation rather than accounting earnings. Over recent quarters, total revenue has moved from US$339.2 million in Q4 2024 to US$248.4 million in Q1 2025, then to US$231.7 million in Q1 2026. Trailing twelve month EPS sits at a loss of US$0.72 alongside FFO of US$399.6 million, setting up a story...

Kontoor Brands (KTB) opened 2026 with Q1 revenue of US$613.3 million and basic EPS of US$1.11, alongside trailing 12 month revenue of about US$3.3 billion and EPS of US$5.02 that reflect the recent 20.6% earnings growth and an 8.3% net margin. Over the past year, the company has seen net income on a trailing 12 month basis move from US$245.8 million to US$278.2 million. During this period, quarterly revenue ranged from US$613.3 million to just over US$1.0 billion, while quarterly EPS ranged...

Amplitude (AMPL) opened Q1 2026 with revenue of US$93.5 million, a basic EPS loss of US$0.17 and net income loss of US$23.3 million, against a backdrop where trailing 12 month revenue stands at US$356.8 million and basic EPS over that period is a loss of US$0.67. Over the last few quarters the company has seen revenue move from US$79.9 million in Q1 2025 to US$93.5 million in Q1 2026, while basic EPS has ranged between a loss of US$0.13 and US$0.19 across those reported periods. This keeps...

Wondering whether Xenon Pharmaceuticals at around US$56 a share still offers value, or if most of the opportunity has already been priced in. The stock has slipped 0.1% over the past week and 2.9% over the past month, yet it is still up 25.9% year to date and 57.6% over the last year. This can change how you think about both upside and risk. Recent attention on Xenon has centered on how its share price performance compares with other biotech stocks and what that says about investor...

Pattern Group (PTRN) opened 2026 with Q1 revenue of US$773.7 million and basic EPS of US$0.17, alongside net income of US$29.2 million.

CRA International (CRAI) opened 2026 with Q1 revenue of US$201 million and basic EPS of US$1.71, while trailing 12 month revenue stood at US$770.7 million and EPS at US$7.27. The company has seen quarterly revenue move from US$181.9 million and EPS of US$2.65 in Q1 2025 to US$200.0 million and EPS of US$1.71 in Q1 2026. This positions investors to weigh forecast earnings growth against a softer net margin profile. Overall, the results put the focus squarely on how much of that earnings power...

Remitly Global (RELY) opened 2026 with Q1 revenue of US$452.8 million and basic EPS of US$0.23, alongside net income of US$49.1 million, as the stock trades around US$22.79. The company has seen quarterly revenue move from US$361.6 million in Q1 2025 to US$452.8 million in Q1 2026, while basic EPS shifted from US$0.06 to US$0.23 over the same period, and trailing 12 month EPS reached US$0.51 on net income of US$105.6 million. For investors, that combination of growing top line and expanding...

U.S. Physical Therapy (USPH) opened 2026 with Q1 revenue of US$196.3 million and basic EPS of a loss of US$0.12, as net income excluding extra items came in at a loss of US$1.8 million. Over the past year, the company has seen quarterly revenue move from US$181.9 million in Q1 2025 to the current US$196.3 million. Over the same period, basic EPS shifted from US$0.80 a share to a loss of US$0.12, and trailing twelve month EPS was US$0.51 on net income of US$7.7 million. These figures may...

Ligand Pharmaceuticals (LGND) opened Q1 2026 with revenue of US$51.7 million and a basic EPS loss of US$0.67, alongside a net loss of US$13.3 million. The company reported revenue of US$45.3 million and a basic EPS loss of US$2.21 in Q1 2025, compared with US$51.7 million and a basic EPS loss of US$0.67 in Q1 2026. Trailing twelve month EPS stood at US$7.87 on net income of US$153.6 million. For investors, the combination of a quarterly loss and a profitable trailing year encourages a closer...